Devyser Diagnostics AB (publ)
DVYSR.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$846.01M
Close$
Share Statistics
| Market cap | $846.01 Million |
|---|---|
| Enterprise Value | $812.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.51 |
| Beta | 0.82 |
| Outstanding Shares | 16,802,100 |
Return
| Return on Equity | 4.02% |
|---|---|
| Return on Assets | 3.10% |
| Return on Invested Capital | 5.85% |
Valuation & Multiples
| P/E Ratio | 55.22 |
|---|---|
| PEG | 239.28 |
| Price to Sales | 3.63 |
| Price to Book Ratio | 2.31 |
| Enterprise Value to Revenue | 3.24 |
| Enterprise Value to EBIT | 32.88 |
| Enterprise Value to Net Income | 53 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 20, 2026
EPS Estimate
$0.27
Average shareholder expectationRevenue Estimate
$70.73 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$57.45 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Devyser Diagnostics AB (publ)
110 employees
CEO: Jan Wahlstrom Headquartered in Hägersten, Sweden, and established in 2004, Devyser Diagnostics AB (publ) specializes in the development, manufacturing, and global sale of advanced diagnostic kits and solutions for DNA testing. The company's innovative...